Politics1 min read

STAT+: Democrats win power to push back on Trump’s health care moves

By · Via STAT Health · Published by Everything Blog

In short

Democrats secured a vital Senate majority on Tuesday night, effectively fracturing the existing Republican trifecta in Washington. According to the Associated Press, the party won at least 51 seats as of 11:36 p.m. EST, though overall vote counting remains ongoing. This political victory delivers their first major opportunity to aggressively challenge the broader Trump administration agenda. With this legislative foothold, party members plan to use oversight and lawmaking powers to counter executive health reforms.

Key points

  • The election outcome effectively shatters the previous Republican trifecta of power acros…: The election outcome effectively shatters the previous Republican trifecta of power across official Washington.
  • Lawmakers now hold their initial major opportunity to challenge the Trump administration'…: Lawmakers now hold their initial major opportunity to challenge the Trump administration's policy agenda.
  • Gaining the majority equips Democrats with legislative tools to conduct oversight and rol…: Gaining the majority equips Democrats with legislative tools to conduct oversight and roll back health reforms.

Sources checked by our analysis pipeline: 1

WASHINGTON — Democrats broke the Republican trifecta of power in Washington Tuesday night, securing powerful new tools to push back on the Trump administration’s health agenda.

Voters granted Democrats control of the Senate in Tuesday’s elections, with the party winning at least 51 seats in the chamber, according to the AP, as of 11:36 p.m. EST. Votes are still being counted, and the final numbers could change.

The win offers Democrats their first major opportunity to rein in Trump’s agenda, creating new paths for oversight over the administration’s health reforms and the possibility of rolling them back through legislation.

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Politics